3 Our portfolio of product candidates is summarized in the figure below: Our lead product candidate, azelaprag: an orally available, small molecule APJ agonist that has the potential to recapitulate the effects of exercise Leveraging our platform, we found that apelin levels decrease with age and that higher levels of apelin are predictive of both improved physical function and increased longevity
Collection Oral Pathology Review Images Contributors Page, Dennis
Dark yellow or amber suggests inadequacy
Long-term follow-up in the DPPOS showed that adherent metformin users maintained roughly 6.2% weight loss below baseline after 15 years, demonstrating durable but modest results particularly in individuals with insulin resistance and higher BMI
In a market crowded with subscription weight loss apps and automated dosing platforms, Prime Surgicare delivers individualized medical weight loss guided by a board-certified bariatric and metabolic surgeon
The SURMOUNT trials , which specifically evaluated tirzepatide for weight management in people without diabetes, similarly demonstrated blood pressure benefits
